About PPDC

Archimedic was selected by the PPDC as its product development partner in the Early Stage Device Support Program. The program is an opportunity designed to provide professional support to guide product development planning and other activities for early stage projects.

Archimedic was founded in 2009, with a focus on translating novel medical concepts and nascent technologies into medical devices meeting functional, regulatory, usability, and manufacturing requirements. The firm has grown to 16 professionals with expertise in industrial design, ergonomics, electro-mechanical engineering, DFM, and transfer into manufacturing.

The Archimedic team includes specialists in product configuration concept development, use case prototyping for formative human factors studies, functional bread-boarding for performance and reliability testing, industrial design encompassing form development and brand integration, design for manufacturability and assembly (DFMA), Alpha/Beta prototyping, supply chain development, pre-production device building, verification and validation, and design transfer into production. Much of their work has been to support development of new and improved technology for various laparoscopic, interventional, and open surgical procedures. Moreover, Archimedic routinely conducts risk management inclusive of design control and design history file management for device programs.

The University of Pittsburgh's McGowan Institute is a global Class III medical device development enterprise , McGowan has been at the forefront of researching, testing, and translating medical devices which have played a critical role in repairing or replacing damaged tissue and organs for 25 years.

McGowan’s partnership brings two strategic advantages to the PPDC: First, McGowan’s Class III device development resources. McGowan has a pediatric device initiative where a large number of their 250+ faculty are either focused on the development of pediatric-centric technologies or where faculty are exploring the adaptation of well-developed adult devices for the pediatric population. Second, McGowan has been a mainstay in the biomedical landscape of Southwestern Pennsylvania for twenty-five years.

The Center for Simulation, Advanced Education and Innovation at CHOP facilitates the translation of scientific discoveries into practical implementation for both research and clinical care. Centralized classroom and skills lab training, satellite skills labs, and unit-based "virtual" lab exercises adjacent to patient care settings are routinely conducted.

The center offers more than 950 teaching sessions with at least 11,000 attendees, including education encompassing recognition of shock and/or cardiac/respiratory failure, vascular access, chest tube care and hemodynamic monitoring, advanced and difficult airway assessment and intervention, pacemaker evaluation, EKG interpretation, critical incident debriefing, and crew resource management. The staff includes multidisciplinary center directors, full-time administrative staff, full-time clinical educators, and additional volunteer faculty.

Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose - to lead the region's technology community to new heights, creating jobs and transforming lives.

For more than 30 years, Ben has been the leading seed stage capital provider for the region's technology sectors, investing over $175 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

NAMSA is the only medical research organization focused exclusively on device, including combination products and in vitro diagnostics. In its 50 years, NAMSA has contributed to bringing thousands of medical devices to patients in need. With backgrounds that include careers at small start-up companies, large industry leaders, FDA and other regulatory agencies prior to joining NAMSA, the breadth and depth of expertise available at NAMSA is unparalleled. NAMSA's Associates are also active participants in shaping the broader medical device industry - participating on numerous ISO working groups with respect to biological and clinical safety. NAMSA Associates are active on AvaMed working groups, and the Medical Device Innovation Consortium - a joint FDA-industry organization focused on innovations in the medical device space.

Penn Health-Tech unites the University of Pennsylvania's strengths in medicine, engineering, business, and education to create technologies that address the world's pressing healthcare needs. It catalyzes medical device innovation at Penn, by providing a connected community and key resources that will maximize the number of medical device innovations that improve patient's lives.

sciVelo is part of the University of Pittsburgh Innovation Institute accelerating life and health sciences translational research and commercialization. sciVelo has a transdisciplinary team of more than 20 practicing scientists, clinicians, and translational research experts. sciVelo's mission is to engage in research of impact by identifying, cultivating and advancing Pitt's most promising life and health sciences translational research to market-ready solutions.